Q12024 funding in pharma, healthcare dips 70% from Q4 2023
As per Tracxn.com data, 58.5 per cent of funding in Q12024 in early-stage rounds
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Deals
Bora Pharmaceuticals acquires Upsher-Smith
The acquisition expands Taiwan-based Bora’s North American footprint with its first US manufacturing site
Biocon Biologics sells branded formulations biz to Eris Lifesciences for INR12.42 bn
Includes portfolio of metabolics, oncology, and critical care products in India and a 10-year supply agreement with Eris
Deal value increased by 19.2 per cent in Jan 2024, compared to Jan 2023: GlobalData
VC investments increased by 11.2 per cent in Jan 2024, compared to Jan 2023
Jubilant Pharma to sell its 25.8 per cent stake in Sofie Biosciences for $139.43 mn
Of this, $113.63 million is expected to be received upon completion of the merger while receipt of balance sum of $25.8 million is…
Bayer, Sun Pharma sign marketing and distribution pact for second brand of Finerenone
Sun Pharma to market the drug under the brand name Lyvelsa
Pharma, healthcare sector attract investment despite volume dip in Q3 2023: Report
The quarter saw 26 deals totalling $2.7 billion, with a 32 per cent decline in deal volumes compared to Q3 2022
Glenmark to divest majority stake in Glenmark Life Sciences to Nirma
Nirma will acquire 75 per cent stake in Glenmark Life Sciences at a price of Rs 615/- per share
Novo Nordisk to acquire Inversago Pharma for up to $1.075 bn
The acquisition of Inversago includes the company’s lead development asset INV-202, an oral CB1 inverse agonist
Sigachi Industries forays into API business, acquires majority stake in Trimax Bio Sciences
The API unit is approved by USFDA for advanced and critical intermediates
Novartis acquires DTx Pharma
Deal includes DTx-1252, a potential therapy for the neuromuscular disorder Charcot-Marie-Tooth disease type 1A (CMT1A), and two…
Glenmark, Cediprof partner to alleviate US amphetamine shortage
Announce exclusive US distribution pact, distribution expected to start during the second half of 2023
Redx, Jounce announce recommended business combination
Combined group will have a strong clinical pipeline and proven expertise in the discovery and development of highly selective…
Control Print, V Shapes announce JV for sustainable packaging solutions in India
This JV will produce recyclable/biodegradable single-use packets for a wide range of products including liquids, viscous and…
Sun Pharma acquires Disperzyme and Phlogam brands to strengthen its anti-inflammatory portfolio
Disperzyme and Phlogam are fixed-dose combinations of proteolytic enzymes and bioflavonoid viz Tryspin, Bromelain and Rutoside…
Prochem joins hands with Tapasya
The new business entity, Prochem Tapasya, will add value to create a one-stop solution for pharma and allied industries
Sun Pharma to acquire Concert Pharma
Under the terms of the merger agreement, Sun Pharma will promptly commence a tender offer to acquire all outstanding shares of…
Quantumzyme and BEC Chemicals collaborate for green chemistry development
The agreement grants both parties access to each other’s knowledge and expertise to develop novel solutions for Active…
BioNTech buys InstaDeep
BioNTech is to pay 362 million pounds upfront, in a mix of cash and an unspecified number of BioNTech shares, and up to 200…
WuXi Biologics and GSK enter into licence agreement on multiple T Cell Engagers
WuXi Biologics will receive a $40 million upfront payment and up to $1.46 billion in additional payments for research,…